Outcomes of hypothetical interventions.

Abstract

<p>I. Decreasing smoking start rate (by testing for COPD predisposition in early smokers).</p><p>II. Decreasing progression rates (by access to new pharmacogenomic agents).</p><p>III. Decreasing exacerbations (by prediction of exacerbators).</p